Objective: Sleep disturbance and sexual dysfunction are common in menopause; however, the nature of their association is unclear. The present study aimed to determine whether sleep characteristics were associated with sexual activity and sexual satisfaction.
S
leep disturbance is associated with adverse health outcomes, including but not limited to heart disease, hypertension, and depression. [1] [2] [3] During menopause, women may experience symptoms that can negatively impact sleep quality and cause sleep disturbance. Sexual functioning and satisfaction are also commonly affected during the menopausal transition and postmenopause. 4 For many women, adequate sleep and sexual functioning are considered important for physical and psychological well-being. However, associations between sleep and sexual function in postmenopausal women are understudied.
Prior work on this topic consists of a few studies that have identified a positive association between obstructive sleep apnea (OSA) and sexual dysfunction in both pre-and postmenopausal women. [5] [6] [7] It is believed that obesity, menopausal symptoms, including vasomotor symptoms, as well as decreasing hormone levels are associated with decreased sexual function and OSA. [5] [6] [7] [8] [9] [10] Moreover, many factors can impact both sleep and sexual function such as general health, age, emotional and psychological issues, life events/changes contributing to stress, social support or lack thereof, recent abuse, medications, and chronic disease. [11] [12] [13] [14] [15] [16] [17] [18] [19] For example, data from the Study of Women's Health Across the Nation demonstrated a co-occurrence of a triad of menopausal symptoms including sleep disturbance, depressed mood, and sexual problems. 20 Beyond OSA, few studies have evaluated how other sleep characteristics (eg, insomnia or sleep duration) may impact sexual function after menopause. A cross-sectional study of 341 Australian postmenopausal women not using menopausal hormone therapy (HT) found that 64% of participants had a diminished libido, which was associated with poor sleep. 21 In a Turkish study, nondepressive postmenopausal women with insomnia were treated with trazodone and sexual function improved during 4 weeks demonstrating a potential link between sleep and sexual problems. 22 A recent prospective study of healthy college-aged women evaluated the influence of sleep duration, sleep quality, and sleep onset latency on daily female sexual response and activity by self-report for 14 days and found that longer sleep duration was related to greater nextday sexual desire and increased odds of sexual activity. 23 Although these women were not postmenopausal, the results indicate a possible physiological link between sleep and sexual function not explained by other comorbidities. To our knowledge, no studies have evaluated how validated insomnia scores, or other sleep risk factors, are associated with sexual function in a large population of postmenopausal women.
The Women's Health Initiative (WHI) Observational Study (OS) offers an opportunity to study how sleep and sexual function are associated in a large cohort of women. The aim of this cross-sectional study was to determine whether selfreported sleep duration, sleep-disordered breathing (SDB) risk and insomnia assessed using a validated, clinically relevant scale are associated with sexual satisfaction and partnered sexual activity.
METHODS The Women's Health Initiative Observational Study
Data were analyzed from postmenopausal women aged 50 to 79 years recruited to the WHI-OS at 40 clinical centers throughout the United States from 1994 to 1998. The design and recruitment for the WHI-OS has been described previously. 24 The study protocol received institutional review board approval at all participating sites and informed consent was collected from all participants. Exclusion criteria for the WHI-OS included survival of less than 3 years, participation in other clinical trials, dementia, alcohol abuse, serious mental illness (eg, schizophrenia, schizoaffective disorder, bipolaraffective disorder), drug dependency, and other medical conditions that precluded adherence and participation. 24 Our analyses include data from the baseline assessments of the 93,668 women enrolled, as well as basic demographic and biometric data collected.
Assessment of sleep characteristics
Self-reported sleep disturbance was examined using four different variables: sleep duration, insomnia, SDB, and comorbid insomnia and SDB risk. 25 
Typical sleep duration
Participants were asked to indicate the number of hours they typically slept each night during the past 4 weeks. Item response choices were 5 or less hours, 6 hours, 7 hours, 8 hours, 9 hours, or 10 or more hours. We categorized these into four groups: very short ( 5 h), short (6 h), average (7-8 h) , and long (!9 h). 26, 27 WHI Insomnia Rating Scale Insomnia was measured using the validated WHI Insomnia Rating Scale (WHIIRS) measure. The five-item scale includes questions on whether participants had trouble falling asleep, woke up several times at night, woke up too early, had trouble getting back to sleep after awakening early, and overall sleep quality (very sound/restful to very restless). Possible scores on the WHIIRS range from 0 to 20, with scores >9 indicating high risk for insomnia. 28 Sleep-disordered breathing SDB was assessed using yes/no questionnaire items for sleep apnea adapted from the Berlin Questionnaire. 29, 30 One point was given for a ''yes'' response to any of the following questions: self-reported snoring !3 times a week, selfreported falling asleep during quiet activities !3 times a week, and either self-reported hypertension or measured obesity (body mass index [BMI] > 30 kg/m 2 ). Possible scores ranged from 0 to 3 points. Scores !2 are considered to be high risk for SBD and <2 low risk.
Comorbid insomnia and SDB
Participants with a high score for both insomnia and SDB, as defined above, were designated as having comorbid insomnia and SDB. Participants with no or only one score above the cutoff for either insomnia or SDB defined as not having comorbid insomnia and SDB.
Assessment of sexual satisfaction and activity
Our primary outcomes included partnered sexual activity (yes vs no) and sexual satisfaction (yes vs no) in the past year. Sexual activity was determined by participants' response to the question ''Did you have any sexual activity with a partner in the last year?'' Sexual satisfaction was determined by participants' response to the question ''How satisfied are you with your current sexual activities, either with a partner or alone?'' Available answer choices included ''very satisfied,'' ''somewhat satisfied,'' ''a little unsatisfied,'' ''very unsatisfied'' or ''don't want to answer.'' We collapsed responses to sexually satisfied (very satisfied and somewhat satisfied) and sexually unsatisfied (a little unsatisfied and very unsatisfied) to create a yes/no outcome variable. Additional sexual activity items included satisfaction with frequency of sexual activity (frequency response choices: less often, satisfied with current frequency, more often, or don't want to answer) and whether participants were worried that sexual activity would affect their health (response choices: not at all worried, a little worried, somewhat worried, very worried, or don't want to answer).
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Other measures
Baseline self-assessment questionnaires were used to collect information on demographic variables, medical history, lifestyle variables, symptoms, medications, and comorbidities. Variables included in the analysis were age; marital status; family income; race/ethnicity; education level; medical history; physical activity (metabolic equivalent hours per week); self-rated health (excellent, very good, good, fair, and poor); cigarette smoking; alcohol use; previous hysterectomy; vaginal dryness (none, mild, moderate, or severe); HT use (never, past, or current); frequency of hot flashes and night sweats (did not occur, mild, moderate, or severe); antidepressant use including selective serotonin reuptake inhibitor (SSRI) use, serotonin-norepinephrine reuptake inhibitor (SNRI) use, and sedative hypnotic use; and sleep medication use. Participants also self-reported the presence or absence of the following medical diseases: osteoporosis, hypertension, cardiovascular disease, arthritis, stroke, presence of cancer (breast, ovarian, and cervical), diabetes, and peripheral arterial disease. BMI was calculated using the weight and height (in kg/m 2 ) that had been measured at the baseline visit.
Depression screening was done through a self-report questionnaire using six items from the 20-item Center for Epidemiological Studies Depression scale (CES-D) and two items from the National Institute of Mental Health's Diagnostic Interview Schedule (DIS). 31 Score ranged from 0 to 1 with higher scores indicating a greater likelihood of depression. Self-reported sociobehavioral covariates included physical and verbal abuse in the last year (no, yes, and it did not upset me too much; yes and it moderately upset me; yes and it upset me very much), as well as the life events scale (assessed number of life events experienced by each participants, for example, partner loss, score scale 0-11 where a higher score indicates that participants experienced a greater number of life-upsetting events), 32, 33 social strain construct (assessed strain on existing support systems based on measurement of negative aspects of social relationship, score scale 9-45 based on responses to nine questions where a higher score indicates greater support), 34 and social support construct (assessed amount of social support the participant had available, score scale 4-20 based on the response to four questions where a higher score indicates greater social strain). 35 
Statistical analysis
We examined cross-sectional associations between sleep variables (sleep duration, insomnia, SDB score and comorbid insomnia, and SDB) and two indicators of sexual function at baseline: sexual activity with a partner (yes/no) and sexual satisfaction (very satisfied/somewhat satisfied vs very unsatisfied/a little unsatisfied) within the last year. Dichotomous or categorical variables were summarized as counts and percentages. We analyzed differences in distributions of dichotomous variables using the x 2 test. If assumptions for the x 2 test were not met, we used the Fisher exact test. We summarized continuous variables as means (standard deviations) and medians (interquartile ranges). We used t tests to analyze differences between distributions of continuous variables. The Wilcoxon rank-sum test was used instead if assumptions for the t test were not met. The cross-sectional association between each risk factor and outcome was evaluated by fitting two multivariate logistic models. The first model adjusted for demographic, physical conditions, and medications that can impact sexual function or sleep, or both, and include age, marital status, family income, race/ethnicity, education level, physical activity, self-rated health, antidepressant use including SSRI use, sedative hypnotic use, sleep medication use, depression as assessed by the CES-D/DIS screening instrument, hysterectomy status, smoking status, weight, and alcohol use. The second multivariate model included the variables in model 1 with the addition of variables that could be considered factors that dampen the association between sleep and sexual function, which include hot flashes, night sweats, osteoporosis, physical and verbal abuse, life events scale, social strain construct, social support construct, vaginal dryness, hypertension, cardiovascular disease, arthritis, stroke, cancer (breast, ovarian, and cervical), diabetes, peripheral arterial disease, obesity (BMI > 30 kg/m 2 ), and HT. Several secondary analyses were performed using the same logistic regression models mentioned above. We excluded data from women with major chronic diseases to explore whether adjustment for presence of a chronic disease impacted the relationship between sleep and sexual function. Similarly, we excluded data from women taking antidepressant medication (SSRI, SNRI, and sedative hypnotics) to identify whether treatment for depression impacted this relationship. We conducted another analysis restricted to women who rated their health as good, very good, or excellent (excluding those who rated their health as fair or poor) to evaluate whether perception of health altered the association between sleep and sexual function. An additional analysis was done that had been planned before analyses that stratified by women living with a partner or not living with a partner to evaluate the associations of partner availability on sexual activity and satisfaction.
Because partner illness, vasomotor symptoms (hot flashes and night sweats), and HT can influence sleep and sexual function, 10, 12, 14, 20, 21, [36] [37] [38] we used interaction terms to test whether associations between sleep and sexual function differed by these covariates. We stratified results when interaction terms were statistically significant. Similarly, we included an interaction term to test whether associations between sleep and sexual function differed by 10-year age category. SAS (version 9.3) was used for data analysis. A P value of <0.05 was considered statistically significant.
RESULTS
Participants were on average 63.6 years old and the majority (83.5%) of participants were non-Hispanic white. The mean BMI was 27.3 kg/m 2 . Selected characteristics of the KLING ET AL study population stratified by sexual satisfaction at baseline are displayed in Table 1 . Fifty-two percent of the participants reported sexual activity with a partner within the last year and 56% reported being somewhat or very satisfied with their current sexual activities, either alone or with a partner. Compared with women who were not satisfied with their current partnered sexual activity, a higher proportion of women who reported satisfaction were married or in an intimate relationship, sexually active in the last year, were nondrinkers, more physically active, and of excellent selfrated health (all P values <0.0001). Similarly, these women reported fewer hot flashes or night sweats and had a lower BMI (all P values <0.0001). Women taking sleep medications or SSRIs, those who were current or past smokers, and those who had previously taken HT were less likely to be satisfied with their current partnered sexual activity (all P values <0.001).
Self-reported sleep characteristics are displayed in Table 2 . The prevalence of insomnia was 31%. Only 19% of participants were at risk for SDB and the average baseline score was 0.85. The majority of participants (60%) reported sleep duration of 7 to 8 hours. Few were identified as having comorbid insomnia and SDB (8%).
Participants with insomnia were less sexually active, less satisfied with their current sexual activity either with a partner or alone, desired sex more often, or were more worried that their sexual activity would affect their health than those without insomnia (Table 3; all P values <0.0001).
Adjusted associations between sleep and sexual function
Lower sleep duration was associated with lower odds of partnered sexual activity. Specifically, those who slept 5 hours or 6 hours had lower odds of partnered sexual activity than those who slept 7 to 8 hours (odds ratio [OR] 0.83, 95% CI, 0.76-0.91 and OR 0.91, 95% CI, 0.86-0.96, respectively). These relationships remained after adjustment for potential confounders (Table 4) .
Similarly, lower sleep duration was associated with lower odds of sexual satisfaction in both models. Compared with those who slept 7 to 8 hours, the odds of sexual satisfaction were lower for those who slept 5 hours (OR 0.83, 95% CI, 0.77-0.89 and OR 0.91) or 6 hours (OR 0.91, 95% CI, 0.86-0.94). The same relationship remained after confounder adjustment. In addition, women with insomnia had lower odds of sexual satisfaction after adjustment for all covariates than those without insomnia. Statistically significant associations between risk of SDB and comorbid SDB and insomnia with sexual satisfaction were not observed.
Secondary analyses
The association between SDB and sexual satisfaction differed by hot flash frequency. However, when we stratified results by hot flash severity, the CI in women with mild hot flashes was 0.88 to 1.00 (OR 0.94), and there were no statistically significant associations identified for women with The association between partnered sexual activity and hours of sleep differed by age category and hormone therapy use. Specifically, the odds of sexual activity with less sleep were lower for older women than for younger women (Fig. 1) . Among women 70 years of age or older, those who slept 5 hours were less likely to be sexually active than those who slept 7 to 8 hours (OR 0.69, 95% CI, 0.57-0.82). A similar but less dramatic relationship was seen for younger women (age 60-69 yrs, OR 0.87, 95% CI, 0.76-0.99 and 59 yrs, OR 0.93, 95% CI, 0.79-1.09). The association between sleep and partnered sexual activity differed by SDB score, but once stratified by age; the relationship was no longer statistically significant for either group. Associations between sleep parameters and partnered sexual activity did not differ significantly by partner illness or vasomotor symptoms.
Stratification by MHT use (never, past, or current) revealed that the never (OR 0.91, 95% CI, 0.82-1.00) and past users (OR 0.85, 95% CI, 0.74-0.98) with insomnia had lower odds of partnered sexual activity than did those without insomnia. However, this relationship was not significant for current users (OR 1.02, 95% CI, 0.94-1.11). Similarly, never users were less likely to be sexually active if they slept 5 hours (OR 0.74, 95% CI, 0.64-0.85) than if they slept 7 to 8 hours, whereas the number of hours slept was not significant for past users (OR 0.83, 95% CI, 0.67-1.03) or current users (OR 1.04, 95% CI, 0.92-1.19).
After excluding data from women with major chronic diseases and antidepressant use (data not shown) findings were similar to the original analysis for both sexual activity and sexual satisfaction. Similarly, when we restricted analysis to women with poor self-rated health, the magnitude and direction of results were similar to those of the primary analysis, whereas the statistical significance was lost, possibly because of sample size reduction (62,011-6,064).
In the subgroup analysis restricted to women living with a partner (data not shown), the results were also similar to the original analyses. However, for women who were living without a partner, results differed from those of the main analysis. Specifically, women living without a partner who In the main analysis, SDB was not significantly associated with sexual function. However, for women not living with a partner those with a higher SDB score had lower odds of sexual activity (OR 0.83, 95% CI, 0.77-0.90), but higher odds of sexual satisfaction (OR 1.10, 95% CI, 1.05-1.16) than women with a lower SDB score. A large proportion of responses were excluded due to missing data on one or more covariates (34% for sexual activity and 43% for sexual satisfaction). We compared key characteristics (age, BMI, ethnicity, education, partner status, alcohol use, history of cardiovascular disease, hypertension, breast cancer, ovarian cancer, cervical cancer or diabetes, vasomotor symptom presence, sleep medications, and SSRI use), between the women who were excluded and those included (results not shown). Overall, the distributions of characteristics were very similar between women included and excluded apart from a few variables. Of those included in the sexual satisfaction analysis, there were higher percentages that were married or in an intimate relationship (73.2% vs 57.3%), and more were white (87.8% vs 77.7%) compared with those excluded. For the sexual activity analysis, more of those that were included had hypertension (36.6% vs 27.1%) and were white (86.8% vs 77.0%) than those that were excluded.
DISCUSSION
In the WHI Observational Study, significant associations between sleep duration, insomnia, and sexual activity and sexual satisfaction were identified. Women who slept less than 7 to 8 hours per night were less likely to be sexually active and sexually satisfied. Those with insomnia were also less likely to be sexually satisfied. These relationships remained after multivariate adjustment accounted for many of the comorbidities that could have explained the relationship between sleep and sexual function, including depression and chronic diseases.
Our findings are consistent with prior literature that has demonstrated an association between less sleep and poor sexual function in other populations. Anderson et al 9 posited that sleep duration was critical to next-day sexual desire in their review of the relationships of sleep, testosterone, and sexual function. Kalmbach et al 23 found that sleep duration in healthy college-age women was related to next-day sexual desire independent of affect and fatigue. Women reported better genital arousal with longer average sleep durations. For partnered women, an additional hour of total sleep time increased their chance of sexual activity by 14%. The National Sleep Foundation's consensus statement on sleep duration recommends optimal ranges of sleep duration as being necessary for overall health and functioning. 27 It appears the same is true for sexual functioning.
Although insomnia is the most prevalent clinical sleep disorder in the United States, 39 its association with sexual function has not been thoroughly examined among women. We were able to use a clinically relevant, validated insomnia scale (WHIIRS) to evaluate the associations between insomnia and sexual function. Our results demonstrated that women with insomnia were less likely to be sexually satisfied, but there was no impact on the likelihood of partnered sexual activity. Just as daytime fatigue and concentration issues can be present for those who suffer from insomnia, decreased sexual satisfaction also may represent a sequelae of the nocturnal symptoms of insomnia. Perhaps the chronic nature of insomnia means women will continue their daily activities, including sexual activity, but their perception of and satisfaction with these activities may be affected by the daytime sequelae of their insomnia.
Unlike prior studies, no significant associations were found between the SDB score (those at risk of OSA) and sexual activity or satisfaction. Previously, reduced sexual function has been identified for women with severe sleep apnea in a dose-related fashion as well as for women with nocturnal hypoxia. 5, 6, 13 We speculate that sleep characteristics of women in our study were not sufficiently disturbed to cause a change to their overall sleep latency or duration to affect sexual function. Alternatively, it is possible that sleep duration, which can be affected by OSA, may be the key component impacting sexual function in the prior studies.
The relationship between sleep characteristics and partnered sexual activity differed across age groups. Older women were less likely to be sexually active if they slept less than 7 to 8 hours per night compared with younger women, possibly related to more comorbidities. In fact, women older than 70 years who slept less than 5 hours were 30% less likely to be sexually active than women sleeping 7 to 8 hours. It has been shown that older age is associated with less partnered sexual activity. 12, 14 It is also known that the prevalence of sleep problems rise with age. 40 Furthermore, poor sleep is associated with shorter sleep durations. 41 An improved understanding of sleep disturbance could positively impact sexual activity in older women.
Menopausal hormone therapy has been shown to attenuate the negative effects of menopausal symptoms on sleep. 42 Our results are in line with these findings. No significant relationship was found between partnered sexual activity and insomnia for current HT users, whereas never or past users with insomnia had lower odds of engagement in sexual activity. Similarly, the relationship between sexual activity and sleep duration was not significant for current HT users, but among women who had never used HT, shorter sleep duration was associated with decreased odds of partnered sexual activity.
Past studies have demonstrated that relationship factors, including the availability of sexual partners and change in relationship status, impact sexual function. [36] [37] [38] Presence of a partner may be protective against sexual dissatisfaction. In our cohort, an interesting relationship between sleep and sexual functioning was identified for women who did not live with a partner. For these women, less sleep was associated with increased odds of sexual activity, but decreased odds of sexual satisfaction. Although the cause of this relationship is unclear, it may indicate different lifestyle factors for women not living with a partner that influences sexual function. It is important to note that sexual satisfaction was not exclusive to having a partner.
Strengths and limitations
Strengths of the current study include the large sample size, and the design of the WHI that included carefully assessed KLING ET AL variables with comprehensive information at baseline. Insomnia was evaluated using a validated, clinically relevant scale (WHIIRS) that can be used in outpatient healthcare settings. To our knowledge, our sample size is significantly larger than previous studies examining the relationship between sleep and sexual function in postmenopausal women.
Limitations of this research include that a large proportion (34% for sexual activity and 43% for sexual satisfaction) of women were excluded in the multivariate analysis due to missing data on one or more of the covariates. However, the number of participants remained high (62,011 for sexual activity, 53,774 for sexual satisfaction) allowing us to evaluate these relationships in a large cohort. Comparison of those included versus excluded showed a higher percentage of white participants included for both sexual health outcomes, and higher percentages of those with hypertension for sexual activity, and higher proportions married or in an intimate relationship for the sexual satisfaction outcome. Additionally, a majority of outcome variables were based upon self-report data, perhaps introducing the potential for misclassification of participants, particularly with regard to sleep characteristics (ie, snoring) that commonly go undetected in women living without partners. Only a small number of sexual function questions were asked in the WHI, limiting our ability to further explore sexual function characteristics in this population. Furthermore, the sexual satisfaction construct is not validated, although it uses wording similar to other validated instruments. We adjusted for a number of potentially important confounders; however, residual confounding due to unmeasured confounders could have affected our association estimates. Many comorbidities such as general health, medications, chronic disease, emotional and psychological issues, affect both sleep and sexual function, which could lead to reverse causation bias in our results. Finally, given the crosssectional design of this study, directionality of the relationships identified cannot be identified. Next steps will include evaluating these relationships over time.
CONCLUSIONS
Our results indicate associations between shorter sleep durations, higher insomnia symptoms, and decreased sexual function, which remained after adjustment for multiple possible confounders. These findings suggest the potential importance of obtaining high-quality and sufficient sleep. Older age and lack of current hormone use were associated with less reported sexual activity when sleep durations were lower than 7 to 8 hours. Prospective, longitudinal investigation of sleep and its impact on sexual function after menopause would help clarify these relationships.
